Development Technologies Corp.
OTC: DVTC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Daniel Kesonen
- Headquarters
- Palm Beach Gardens, United States
- IPO year
- 1997
- Market cap
- $272.5M
- Website
- https://www.pegasusbiosciences.com
Loading DVTC…
Loading profile data…Frequently asked questions about DVTC
What does Development Technologies Corp. (DVTC) do?
Pegasus Pharmaceuticals Inc. develops and supplies the HeartVue 6S System, an advanced electrocardiogram (ECG) device engineered for the non-invasive detection and diagnosis of a spectrum of heart and cardiac conditions. Its utility extends to a broad spectrum of medical practitioners, including cardiologists, general practitioners, and other ph...
Where does DVTC trade?
Development Technologies Corp. (DVTC) trades on the Other OTC.
What sector is DVTC in?
Development Technologies Corp. (DVTC) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Development Technologies Corp.?
Daniel Kesonen is the chief executive officer of Development Technologies Corp. (DVTC).
Where is Development Technologies Corp. headquartered?
Development Technologies Corp. is headquartered in United States.
Does DVTC pay a dividend?
Development Technologies Corp. (DVTC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DVTC go public?
Development Technologies Corp. (DVTC) completed its initial public offering in 1997.